EUR-1100

DRUG2 trials

Sponsors

Forest Laboratories

Conditions

Eosinophilic Esophagitis

Phase 1

Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis

CompletedNCT01386112

Forest LaboratoriesEosinophilic Esophagitis

Start: 2011-09-30End: 2012-10-31Updated: 2012-11-02

Unknown Phase

A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

CompletedNCT01498497

Forest LaboratoriesEosinophilic Esophagitis

Start: 2012-01-31End: 2013-04-30Updated: 2017-02-09

Related Papers

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

2018-11-2318 citations